Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| Selexis SA, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 4 | 2 |
| Selexis SA, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 6 | 1 |
| Selexis SA, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 7 | 1 |
| Selexis SA, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 8 | 1 |
| Selexis SA, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 9 | 2 |
| Selexis SA, Pharmaceuticals &Healthcare, Deal Details | 11 | 25 |
| Partnerships | 11 | 1 |
| Complix Partners with Selexis | 11 | 1 |
| Faron Pharma Enters into Agreement with Selexis | 12 | 1 |
| JHL Biotech Enters Into Agreement With Selexis For Drug Development | 13 | 1 |
| Selexis Enters Into Partnership Agreement With Fusion Antibodies | 14 | 1 |
| Oncobiologics Enters into Research Agreement with Selexis | 15 | 1 |
| BIOCRATES Life Sciences Enters Into Co-Development Agreement With Selexis | 16 | 1 |
| Laureate Pharma Enters Into An Agreement With Selexis | 17 | 1 |
| Licensing Agreements | 18 | 1 |
| Pieris Pharma Enters into Licensing Agreement with Selexis | 18 | 1 |
| Turgut Ilaclari Enters into Licensing Agreement with Selexis | 19 | 1 |
| Progenics Pharma Enters into Licensing Agreement with Selexis | 20 | 1 |
| Laboratorios Liomont Enters into Licensing Agreement with Selexis | 21 | 1 |
| Opthea Enters Into Licensing Agreement With Selexis For Wet AMD Product | 22 | 1 |
| Oncobiologics Exercises Option for Licensing Agreement with Selexis for ONS-1045 | 23 | 2 |
| Oncobiologics Exercises Option for Licensing Agreement with Selexis for ONS-1050 | 25 | 2 |
| Oncobiologics Exercises Option for Licensing Agreement with Selexis for ONS-3010 | 27 | 2 |
| Selexis Expands License Agreement With Amgen | 29 | 1 |
| Selexis Enters Into Licensing Agreement With CSL | 30 | 1 |
| Selexis Enters Into Licensing Agreement With Neogenix Oncology | 31 | 1 |
| Asset Transactions | 32 | 1 |
| Agenus Enters Acquires Rights to Cell Line Development Technology from Selexis | 32 | 1 |
| Ligand Pharma Acquires Financial Rights to More Than 15 Biologic Development Programs from Selexis for USD4 Million | 33 | 1 |
| Ligand Pharma Acquires Financial Rights To Over 15 Biologic Development Programs Of Selexis For Up To US$4.5 Million | 34 | 2 |
| Selexis SA - Key Competitors | 36 | 1 |
| Key Employees | 37 | 1 |
| Locations And Subsidiaries | 38 | 1 |
| Head Office | 38 | 1 |
| Other Locations &Subsidiaries | 38 | 1 |
| Appendix | 39 | 1 |
| Methodology | 39 | 1 |
| About GlobalData | 39 | 1 |
| Contact Us | 39 | 1 |
| Disclaimer | 39 | 1 |